Sakib Mahmud , Faizul Rakib Sayem , Manal Hassan , Yanjun Yang , Muhammad E.H. Chowdhury , Susu M. Zughaier , Faycal Bensaali , Yiping Zhao
{"title":"Deep learning-based cross-device standardization of surface-enhanced Raman spectroscopy for enhanced bacterial recognition","authors":"Sakib Mahmud , Faizul Rakib Sayem , Manal Hassan , Yanjun Yang , Muhammad E.H. Chowdhury , Susu M. Zughaier , Faycal Bensaali , Yiping Zhao","doi":"10.1016/j.saa.2025.126931","DOIUrl":null,"url":null,"abstract":"<div><div>Surface-enhanced Raman spectroscopy (SERS) is a powerful, label-free technique for pathogen detection; however, its broader adoption in clinical diagnostics is hindered by inconsistent spectral quality across portable and laboratory-grade instruments, limited cross-device reproducibility, and the poor generalizability of existing machine learning approaches. These limitations restrict reliable and rapid pathogen identification at the point of care. To address this gap, we collected SERS spectra from analytes spread on silver nanorod (AgNR) substrates using four portable Raman systems (Enwave, Tec5, First Defender, and Rapid ID) and one laboratory-grade reference device (Renishaw). The dataset included 20 analyte classes representing clinically relevant bacterial signatures and reference compounds. We propose a deep learning framework comprising: (1) SERS-D2DNet, a one-dimensional sequence-to-sequence neural network that transforms spectra from portable devices into high-fidelity laboratory-grade equivalents, and (2) SuperRaman, a lightweight super-operational neural network (Super-ONN) for efficient multiclass bacterial classification. Primary and ablation studies confirm the complementary role of domain transformation and classification, demonstrating improved feature separability and reduced misclassification rates. Quantitative results show that SERS-D2DNet reduced mean absolute error to 0.01 and increased R<sup>2</sup> to over 98 % across devices, while SuperRaman achieved up to 100 % classification accuracy post-transformation. Compared to existing approaches, SERS-D2DNet delivered the lowest MAE (0.024 to 0.034), while SuperRaman surpassed state-of-the-art classifiers. The combined framework requires only 6.6 million parameters, a compact 9 MB footprint, and a 3.27 ms inference time, making it well-suited for portable deployment. This study establishes a scalable, real-time solution for rapid sepsis detection and pathogen identification, bridging the performance gap between portable and laboratory-grade SERS systems.</div></div>","PeriodicalId":433,"journal":{"name":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","volume":"347 ","pages":"Article 126931"},"PeriodicalIF":4.6000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1386142525012387","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SPECTROSCOPY","Score":null,"Total":0}
引用次数: 0
Abstract
Surface-enhanced Raman spectroscopy (SERS) is a powerful, label-free technique for pathogen detection; however, its broader adoption in clinical diagnostics is hindered by inconsistent spectral quality across portable and laboratory-grade instruments, limited cross-device reproducibility, and the poor generalizability of existing machine learning approaches. These limitations restrict reliable and rapid pathogen identification at the point of care. To address this gap, we collected SERS spectra from analytes spread on silver nanorod (AgNR) substrates using four portable Raman systems (Enwave, Tec5, First Defender, and Rapid ID) and one laboratory-grade reference device (Renishaw). The dataset included 20 analyte classes representing clinically relevant bacterial signatures and reference compounds. We propose a deep learning framework comprising: (1) SERS-D2DNet, a one-dimensional sequence-to-sequence neural network that transforms spectra from portable devices into high-fidelity laboratory-grade equivalents, and (2) SuperRaman, a lightweight super-operational neural network (Super-ONN) for efficient multiclass bacterial classification. Primary and ablation studies confirm the complementary role of domain transformation and classification, demonstrating improved feature separability and reduced misclassification rates. Quantitative results show that SERS-D2DNet reduced mean absolute error to 0.01 and increased R2 to over 98 % across devices, while SuperRaman achieved up to 100 % classification accuracy post-transformation. Compared to existing approaches, SERS-D2DNet delivered the lowest MAE (0.024 to 0.034), while SuperRaman surpassed state-of-the-art classifiers. The combined framework requires only 6.6 million parameters, a compact 9 MB footprint, and a 3.27 ms inference time, making it well-suited for portable deployment. This study establishes a scalable, real-time solution for rapid sepsis detection and pathogen identification, bridging the performance gap between portable and laboratory-grade SERS systems.
期刊介绍:
Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy (SAA) is an interdisciplinary journal which spans from basic to applied aspects of optical spectroscopy in chemistry, medicine, biology, and materials science.
The journal publishes original scientific papers that feature high-quality spectroscopic data and analysis. From the broad range of optical spectroscopies, the emphasis is on electronic, vibrational or rotational spectra of molecules, rather than on spectroscopy based on magnetic moments.
Criteria for publication in SAA are novelty, uniqueness, and outstanding quality. Routine applications of spectroscopic techniques and computational methods are not appropriate.
Topics of particular interest of Spectrochimica Acta Part A include, but are not limited to:
Spectroscopy and dynamics of bioanalytical, biomedical, environmental, and atmospheric sciences,
Novel experimental techniques or instrumentation for molecular spectroscopy,
Novel theoretical and computational methods,
Novel applications in photochemistry and photobiology,
Novel interpretational approaches as well as advances in data analysis based on electronic or vibrational spectroscopy.